Shuo Xu

Title: Shuo Xu: Innovator in Pharmaceutical Development

Introduction

Shuo Xu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on improving drug delivery systems to enhance patient outcomes.

Latest Patents

Shuo Xu holds a patent for an oral solid tablet comprising Bruton's Tyrosine Kinase inhibitor and its preparation method. The patent describes an oral solid tablet that includes (S)-7-[4-(1-acryloylpiperidine)]-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide. This formulation exhibits excellent drug release characteristics, ensuring easy administration and quick, efficient release. The preparation process is straightforward, requiring no special equipment, which contributes to formulation stability and facilitates transportation and storage. This innovation is particularly suitable for large-scale production.

Career Highlights

Shuo Xu is currently employed at BeiGene Switzerland GmbH, where he continues to advance his research and development efforts in the pharmaceutical industry. His work is characterized by a commitment to enhancing drug formulations and improving therapeutic efficacy.

Collaborations

Shuo Xu collaborates with notable colleagues, including Gang Qiu and Yiwei Shen, to further his research initiatives and drive innovation in drug development.

Conclusion

Shuo Xu's contributions to pharmaceutical innovations, particularly through his patented oral solid tablet, highlight his role as a key inventor in the industry. His work not only improves drug delivery but also paves the way for future advancements in pharmaceutical formulations.